Cargando…
Sevoflurane: Nephrogenic diabetes insipidus following off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023693/ http://dx.doi.org/10.1007/s40278-022-13902-z |
Ejemplares similares
-
Sevoflurane: Nephrogenic diabetes insipidus: 2 case reports
Publicado: (2021) -
Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
por: Honore, Patrick M., et al.
Publicado: (2019) -
Nephrogenic Diabetes Insipidus following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression
por: Dupuis, Camie, et al.
Publicado: (2022) -
Bendamustine-induced nephrogenic diabetes insipidus – A case report
por: Desjardins, Audrey, et al.
Publicado: (2021) -
Congenital nephrogenic diabetes insipidus accompanied with central nephrogenic diabetes secondary to pituitary surgery -a case report
por: Zhang, Wei, et al.
Publicado: (2021)